{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T13:40:02Z","timestamp":1748526002485,"version":"3.41.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.bcp.2015.07.003","type":"journal-article","created":{"date-parts":[[2015,7,20]],"date-time":"2015-07-20T17:43:19Z","timestamp":1437414199000},"page":"322-326","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Triggle effect"],"prefix":"10.1016","volume":"98","author":[{"given":"Terrance P.","family":"Snutch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald W.","family":"Zamponi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2 Pt 2","key":"10.1016\/j.bcp.2015.07.003_bib0005","first-page":"I3","article-title":"History of calcium antagonists","volume":"52","author":"Fleckenstein","year":"1983","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.bcp.2015.07.003_bib0010","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0022-3565(25)23882-4","article-title":"Pharmacologic and radioligand binding analysis of the actions of 1,4-dihydropyridine activator-antagonist pairs in smooth muscle","volume":"239","author":"Wei","year":"1986","journal-title":"J. Pharmacol. Exp. Therap."},{"issue":"11","key":"10.1016\/j.bcp.2015.07.003_bib0015","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1021\/jm00119a009","article-title":"1,4-Dihydropyridine antagonist activities at the calcium channel: a quantitative structure-activity relationship approach","volume":"31","author":"Coburn","year":"1988","journal-title":"J. Med. Chem."},{"issue":"23","key":"10.1016\/j.bcp.2015.07.003_bib0020","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1021\/jm00075a034","article-title":"A homologous series of permanently charged 1,4-dihydropyridines: novel probes designed to localize drug binding sites on ion channels","volume":"36","author":"Baindur","year":"1993","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bcp.2015.07.003_bib0025","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0026-895X(25)09797-4","article-title":"L-type calcium channels: asymmetrical intramembrane binding domain revealed by variable length, permanently charged 1,4-dihydropyridines","volume":"46","author":"Bangalore","year":"1994","journal-title":"Mol. Pharmacol."},{"issue":"15","key":"10.1016\/j.bcp.2015.07.003_bib0030","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1021\/jm000028l","volume":"43","author":"Peri","year":"2000","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2015.07.003_bib0035","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0022-3565(25)10629-0","article-title":"Calcium channel antagonists: cardiovascular selectivity of action","volume":"274","author":"Sun","year":"1995","journal-title":"J. Pharmacol. Exp. Therap."},{"issue":"3","key":"10.1016\/j.bcp.2015.07.003_bib0040","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1023\/A:1023632419813","article-title":"1,4-Dihydropyridines as calcium channel ligands and privileged structures","volume":"23","author":"Triggle","year":"2003","journal-title":"Cell Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.bcp.2015.07.003_bib0045","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2174\/1389557033488141","article-title":"The 1,4-dihydropyridine nucleus: a pharmacophoric template part 1. Actions at ion channels","volume":"3","author":"Triggle","year":"2003","journal-title":"Mini Rev. Med. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2015.07.003_bib0050","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1124\/mol.61.3.649","article-title":"Synthesis and evaluation of a new class of nifedipine analogs with T-type calcium channel blocking activity","volume":"61","author":"Kumar","year":"2002","journal-title":"Mol. Pharmacol."},{"issue":"7","key":"10.1016\/j.bcp.2015.07.003_bib0055","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s00424-013-1376-z","article-title":"Synthesis and evaluation of 1,4-dihydropyridine derivatives with calcium channel blocking activity","volume":"466","author":"Bladen","year":"2014","journal-title":"Pflugers Archiv: Eur. J. Physiol."},{"issue":"6","key":"10.1016\/j.bcp.2015.07.003_bib0060","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s00424-014-1566-3","article-title":"1,4-Dihydropyridine derivatives with T-type calcium channel blocking activity attenuate inflammatory and neuropathic pain","volume":"467","author":"Bladen","year":"2015","journal-title":"Pflugers Archiv: Eur. J. Physiol."},{"issue":"29","key":"10.1016\/j.bcp.2015.07.003_bib0065","doi-asserted-by":"crossref","first-page":"14337","DOI":"10.1016\/S0021-9258(18)47943-4","article-title":"Identification of a novel 1,4-dihydropyridine- and phenylalkylamine-binding polypeptide in calcium channel preparations","volume":"262","author":"Vaghy","year":"1987","journal-title":"J. Biol. Chem."},{"issue":"23","key":"10.1016\/j.bcp.2015.07.003_bib0070","doi-asserted-by":"crossref","first-page":"9108","DOI":"10.1073\/pnas.87.23.9108","article-title":"Identification of a phenylalkylamine binding region within the alpha 1 subunit of skeletal muscle Ca2+ channels","volume":"87","author":"Striessnig","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"38","key":"10.1016\/j.bcp.2015.07.003_bib0075","doi-asserted-by":"crossref","first-page":"22119","DOI":"10.1074\/jbc.270.38.22119","article-title":"Molecular determinants of high affinity phenylalkylamine block of L-type calcium channels","volume":"270","author":"Hockerman","year":"1995","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.bcp.2015.07.003_bib0080","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/S0026-895X(25)09574-4","article-title":"Distinct effects of mutations in transmembrane segment IVS6 on block of L-type calcium channels by structurally similar phenylalkylamines","volume":"50","author":"Johnson","year":"1996","journal-title":"Mol. Pharmacol."},{"issue":"30","key":"10.1016\/j.bcp.2015.07.003_bib0085","doi-asserted-by":"crossref","first-page":"18759","DOI":"10.1074\/jbc.272.30.18759","article-title":"Molecular determinants of high affinity phenylalkylamine block of L-type calcium channels in transmembrane segment IIIS6 and the pore region of the alpha1 subunit","volume":"272","author":"Hockerman","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"20","key":"10.1016\/j.bcp.2015.07.003_bib0090","doi-asserted-by":"crossref","first-page":"9203","DOI":"10.1073\/pnas.88.20.9203","article-title":"Identification of 1,4-dihydropyridine binding regions within the alpha 1 subunit of skeletal muscle Ca2+ channels by photoaffinity labeling with diazipine","volume":"88","author":"Nakayama","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.bcp.2015.07.003_bib0095","doi-asserted-by":"crossref","first-page":"5293","DOI":"10.1074\/jbc.271.10.5293","article-title":"Molecular determinants of high affinity dihydropyridine binding in L-type calcium channels","volume":"271","author":"Peterson","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"16","key":"10.1016\/j.bcp.2015.07.003_bib0100","doi-asserted-by":"crossref","first-page":"12730","DOI":"10.1074\/jbc.M010164200","article-title":"Mechanism of dihydropyridine interaction with critical binding residues of L-type Ca2+ channel alpha 1 subunits","volume":"276","author":"Wappl","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"44","key":"10.1016\/j.bcp.2015.07.003_bib0105","doi-asserted-by":"crossref","first-page":"27686","DOI":"10.1074\/jbc.272.44.27686","article-title":"Nine L-type amino acid residues confer full 1,4-dihydropyridine sensitivity to the neuronal calcium channel alpha1A subunit. Role of L-type Met1188","volume":"272","author":"Sinnegger","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"33","key":"10.1016\/j.bcp.2015.07.003_bib0110","doi-asserted-by":"crossref","first-page":"20113","DOI":"10.1074\/jbc.271.33.20113","article-title":"Identification of benz(othi) azepine-binding regions within L-type calcium channel alpha1 subunits","volume":"271","author":"Kraus","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"42","key":"10.1016\/j.bcp.2015.07.003_bib0115","doi-asserted-by":"crossref","first-page":"27205","DOI":"10.1074\/jbc.273.42.27205","article-title":"Molecular mechanism of diltiazem interaction with L-type Ca2+ channels","volume":"273","author":"Kraus","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bcp.2015.07.003_bib0120","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1602\/neurorx.2.4.662","article-title":"Targeting chronic and neuropathic pain: the N-type calcium channel comes of age","volume":"2","author":"Snutch","year":"2005","journal-title":"NeuroRx"},{"issue":"11","key":"10.1016\/j.bcp.2015.07.003_bib0125","doi-asserted-by":"crossref","first-page":"5058","DOI":"10.1073\/pnas.89.11.5058","article-title":"Molecular cloning of the alpha-1 subunit of an omega-conotoxin-sensitive calcium channel","volume":"89","author":"Dubel","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.bcp.2015.07.003_bib0130","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1523\/JNEUROSCI.16-08-02430.1996","article-title":"Beta subunit coexpression and the alpha1 subunit domain I-II linker affect piperidine block of neuronal calcium channels","volume":"16","author":"Zamponi","year":"1996","journal-title":"J. Neurosci."},{"issue":"15","key":"10.1016\/j.bcp.2015.07.003_bib0135","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1021\/jm9602928","article-title":"The properties of known drugs. 1. Molecular frameworks","volume":"39","author":"Bemis","year":"1996","journal-title":"J. Med. Chem."},{"issue":"1-2","key":"10.1016\/j.bcp.2015.07.003_bib0140","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.drudis.2006.11.011","article-title":"Drugs in other drugs: a new look at drugs as fragments","volume":"12","author":"Siegel","year":"2007","journal-title":"Drug Disc Today"},{"issue":"Suppl. 2","key":"10.1016\/j.bcp.2015.07.003_bib0145","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1111\/jns.12080_2","article-title":"Z944: a first in class T-type calcium channel modulator for the treatment of pain","volume":"19","author":"Lee","year":"2014","journal-title":"J. peripheral Nerv. Syst.: JPNS"},{"issue":"2","key":"10.1016\/j.bcp.2015.07.003_bib0150","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1523\/JNEUROSCI.22-02-00396.2002","article-title":"Differential inhibition of T-type calcium channels by neuroleptics","volume":"22","author":"Santi","year":"2002","journal-title":"J. Neurosci."},{"issue":"121","key":"10.1016\/j.bcp.2015.07.003_bib0155","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003120","article-title":"T-type calcium channel blockers that attenuate thalamic burst firing and suppress absence seizures","volume":"4","author":"Tringham","year":"2012","journal-title":"Sci. Transl. Med"},{"issue":"4","key":"10.1016\/j.bcp.2015.07.003_bib0160","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.pain.2010.12.035","article-title":"A novel slow-inactivation-specific ion channel modulator attenuates neuropathic pain","volume":"152","author":"Hildebrand","year":"2011","journal-title":"pain"},{"key":"10.1016\/j.bcp.2015.07.003_bib0165","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0896-6273(00)80037-9","article-title":"Transfer of 1,4-dihydropyridine sensitivity from L-type to class A (BI) calcium channels","volume":"16","author":"Grabner","year":"1996","journal-title":"Neuron"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295215003676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295215003676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T13:10:07Z","timestamp":1748524207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295215003676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0006295215003676"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2015.07.003","relation":{},"ISSN":["0006-2952"],"issn-type":[{"type":"print","value":"0006-2952"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Triggle effect","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2015.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}